SCHEMBL29636987

SCHEMBL29636987

Nc1ncnc(Cl)c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918611 1.00
Bromide SCHEMBL30063554 0.98 HTT (0.36)
SCHEMBL8386307 0.84
SCHEMBL12559248 0.81
SCHEMBL7118036 0.74
SCHEMBL29799474 0.74
SCHEMBL783585 0.74
SCHEMBL1440581 0.74
SCHEMBL25036984 0.70
SCHEMBL846275 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025061148-A1 HETEROARYL COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2025-03-27 WO disclosed
EP-4337198-A1 POLO LIKE KINASE 4 INHIBITORS Oric Pharmaceuticals, Inc. (US) 2024-03-20 EP disclosed
WO-2022240876-A1 POLO LIKE KINASE 4 INHIBITORS ORIC PHARMACEUTICALS, INC. (US) 2022-11-17 WO disclosed
WO-2022094172-A2 INHIBITORS OF BTK NEWAVE PHARMACEUTICAL INC. (US) 2022-05-05 WO disclosed